![Frontiers | Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy Frontiers | Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy](https://www.frontiersin.org/files/Articles/730257/fphar-12-730257-HTML/image_m/fphar-12-730257-g007.jpg)
Frontiers | Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy
![Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABAA Receptor | Journal of Pharmacology and Experimental Therapeutics Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABAA Receptor | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/372/1/1/F1.large.jpg)
Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABAA Receptor | Journal of Pharmacology and Experimental Therapeutics
![PDF) Padsevonil randomized Phase IIa trial in treatment-resistant focal epilepsy: a translational approach PDF) Padsevonil randomized Phase IIa trial in treatment-resistant focal epilepsy: a translational approach](https://www.researchgate.net/publication/347378405/figure/fig4/AS:983486856962050@1611492947803/Median-change-in-seizure-frequency-throughout-the-proof-of-concept-trial-Treatment-with_Q320.jpg)
PDF) Padsevonil randomized Phase IIa trial in treatment-resistant focal epilepsy: a translational approach
![Frontiers | Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy Frontiers | Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy](https://www.frontiersin.org/files/Articles/730257/fphar-12-730257-HTML/image_m/fphar-12-730257-g002.jpg)
Frontiers | Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy
PROTOCOL EP0091 AMENDMENT 2 ARISE: pAdsevonil in drug-ResIStant Epilepsy A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE FI
![Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABAA Receptor | Journal of Pharmacology and Experimental Therapeutics Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABAA Receptor | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/372/1/1/F3.large.jpg)
Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABAA Receptor | Journal of Pharmacology and Experimental Therapeutics
![Fundamental Neurochemistry Review: GABAA receptor neurotransmission and epilepsy: Principles, disease mechanisms and pharmacotherapy - Bryson - 2023 - Journal of Neurochemistry - Wiley Online Library Fundamental Neurochemistry Review: GABAA receptor neurotransmission and epilepsy: Principles, disease mechanisms and pharmacotherapy - Bryson - 2023 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ed573bbc-0d4d-4015-91ae-423704bfa6d1/jnc15769-fig-0005-m.jpg)
Fundamental Neurochemistry Review: GABAA receptor neurotransmission and epilepsy: Principles, disease mechanisms and pharmacotherapy - Bryson - 2023 - Journal of Neurochemistry - Wiley Online Library
![Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies | Journal of Medicinal Chemistry Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.2c01975/asset/images/large/jm2c01975_0016.jpeg)
Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies | Journal of Medicinal Chemistry
Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies | Journal of Medicinal Chemistry
![The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond | SpringerLink The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40263-021-00827-8/MediaObjects/40263_2021_827_Fig5_HTML.png)
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond | SpringerLink
![Proceedings of the 15th Antiepileptic Drug and Device Trials Meeting: State of the Science - Epilepsy & Behavior Proceedings of the 15th Antiepileptic Drug and Device Trials Meeting: State of the Science - Epilepsy & Behavior](https://www.epilepsybehavior.com/cms/asset/05eff367-9baf-48ef-8b82-0ed3e0f994e5/gr1.jpg)